Skip to main content
Christina Cho, MD, Oncology, Hackensack, NJ, Hackensack Meridian Health Hackensack University Medical Center

ChristinaChoMD

Oncology Hackensack, NJ

Physician

Overview of Dr. Cho

Dr. Christina Cho is an oncologist in Hackensack, NJ and is affiliated with multiple hospitals in the area, including Hackensack Meridian Health Hackensack University Medical Center and Hackensack Meridian Health Jersey Shore University Medical Center. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 6 years. She is one of 130 doctors at Hackensack Meridian Health Hackensack University Medical Center and one of 41 doctors at Hackensack Meridian Health Jersey Shore University Medical Center who specialize in Oncology. She has more than 60 publications and over 500 citings.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2014
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 2011
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2013 - Present
  • NJ State Medical License
    NJ State Medical License 2022 - 2025
  • NY State Medical License
    NY State Medical License 2014 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Inductee Alpha Omega Alpha Honor Medical Society, 2011

Publications & Presentations

PubMed

Abstracts/Posters

  • Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell Transplantation
    Christina Cho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First RemissionClinically Relevant Abstract
    Christina Cho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on C... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Professional Memberships

Hospital Affiliations